![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2023
Issels, Rolf D. 
ORCID: https://orcid.org/0000-0002-3494-6561; Böck, Stefan; Pelzer, Uwe; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Ghadjar, Pirus; Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264; Albertsmeier, Markus ORCID: https://orcid.org/0000-0002-5028-5062; Angele, Martin K.; Schmidt, Michael ORCID: https://orcid.org/0000-0001-5898-9323; Xu, Yujun ORCID: https://orcid.org/0000-0002-8487-7584; Bahra, Marcus; Pratschke, Johann; Schoenberg, Michael; Thasler, Wolfgang E.; Salat, Christoph; Stoetzer, Oliver J.; Knoefel, Wolfram T.; Graf, Dirk; Wessalowski, Rüdiger; Keitel-Anselmino, Verena; Koenigsrainer, Alfred; Bitzer, Michael ORCID: https://orcid.org/0000-0002-4463-8263; Zips, Daniel; Bamberg, Michael; Fietkau, Rainer; Ott, Oliver; Kawecki, Maciej ORCID: https://orcid.org/0000-0001-7858-6214; Wyrwicz, Lucjan; Rutkowski, Piotr; Rentsch, Markus; Ababei, Juliana; Reichardt, Peter; Rigamonti, Marco; Weber, Bernhard; Abdel-Rahman, Sultan; Tschoep–Lechner, Katharina; Jauch, Karl-Walter; Bruns, Christiane J.; Oettle, Helmut; Bergwelt-Baildon, Michael von; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Werner, Jens
(2023):
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.
In: European Journal of Cancer (EJC), Bd. 181: S. 155-165
ORCID: https://orcid.org/0000-0002-3494-6561; Böck, Stefan; Pelzer, Uwe; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Ghadjar, Pirus; Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264; Albertsmeier, Markus ORCID: https://orcid.org/0000-0002-5028-5062; Angele, Martin K.; Schmidt, Michael ORCID: https://orcid.org/0000-0001-5898-9323; Xu, Yujun ORCID: https://orcid.org/0000-0002-8487-7584; Bahra, Marcus; Pratschke, Johann; Schoenberg, Michael; Thasler, Wolfgang E.; Salat, Christoph; Stoetzer, Oliver J.; Knoefel, Wolfram T.; Graf, Dirk; Wessalowski, Rüdiger; Keitel-Anselmino, Verena; Koenigsrainer, Alfred; Bitzer, Michael ORCID: https://orcid.org/0000-0002-4463-8263; Zips, Daniel; Bamberg, Michael; Fietkau, Rainer; Ott, Oliver; Kawecki, Maciej ORCID: https://orcid.org/0000-0001-7858-6214; Wyrwicz, Lucjan; Rutkowski, Piotr; Rentsch, Markus; Ababei, Juliana; Reichardt, Peter; Rigamonti, Marco; Weber, Bernhard; Abdel-Rahman, Sultan; Tschoep–Lechner, Katharina; Jauch, Karl-Walter; Bruns, Christiane J.; Oettle, Helmut; Bergwelt-Baildon, Michael von; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Werner, Jens
(2023):
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.
In: European Journal of Cancer (EJC), Bd. 181: S. 155-165
2021
Adam, M. Gordian; Beyer, Georg; Christiansen, Nicole; Kamlage, Beate; Pilarsky, Christian; Distler, Marius; Fahlbusch, Tim; Chromik, Ansgar; Klein, Fritz; Bahra, Marcus; Uhl, Waldemar; Gruetzmann, Robert; Mahajan, Ujjwal M.; Weiss, Frank U.; Mayerle, Julia und Lerch, Markus M.
(2021):
Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
In: Gut, Bd. 70, Nr. 11: S. 2150-2158
Kunzmann, Volker; Siveke, Jens T.; Alguel, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J.; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bahra, Marcus; Jakobs, Ralf; Hartlapp, Ingo und Heinemann, Volker
(2021):
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
In: Lancet Gastroenterology & Hepatology, Bd. 6, Nr. 2: S. 128-138
2018
Muckenhuber, Alexander; Berger, Anne Katrin; Schlitter, Anna Melissa; Steiger, Katja; Konukiewitz, Björn; Trumpp, Andreas; Eils, Roland; Werner, Jens; Friess, Helmut; Esposito, Irene; Kloeppel, Guenter; Ceyhan, Gueralp O.; Jesinghaus, Moritz; Denkert, Carsten; Bahra, Marcus; Stenzinger, Albrecht; Sprick, Martin R.; Jaeger, Dirk; Springfeld, Christoph und Weichert, Wilko
(2018):
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
In: Clinical Cancer Research, Bd. 24, Nr. 2: S. 351-359
2017
Diener, Markus K.; Hüttner, Felix J.; Kieser, Meinhard; Knebel, Phillip; Dörr-Harim, Colette; Distler, Marius; Grützmann, Robert; Wittel, Uwe A.; Schirren, Rebekka; Hau, Hans-Michael; Kleespies, Axel; Heidecke, Claus-Dieter; Tomazic, Ales; Halloran, Christopher M.; Wilhelm, Torsten J.; Bahra, Marcus; Beckurts, Tobias; Boerner, Thomas; Glanemann, Matthias; Steger, Ulrich; Treitschke, Frank; Staib, Ludger; Thelen, Karsten; Brückner, Thomas; Mihaljevic, Andre L.; Werner, Jens; Ulrich, Alexis; Hackert, Thilo und Büchler, Markus W.
(2017):
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial.
In: Lancet, Bd. 390, Nr. 10099: S. 1027-1037
2016
Noll, Elisa M.; Eisen, Christian; Stenzinger, Albrecht; Espinet, Elisa; Muckenhuber, Alexander; Klein, Corinna; Vogel, Vanessa; Klaus, Bernd; Nadler, Wiebke; Rösli, Christoph; Lutz, Christian; Kulke, Michael; Engelhardt, Jan; Zickgraf, Franziska M.; Espinosa, Octavio; Schlesner, Matthias; Jiang, Xiaoqi; Kopp-Schneider, Annette; Neuhaus, Peter; Bahra, Marcus; Sinn, Bruno V.; Eils, Roland; Giese, Nathalia A.; Hackert, Thilo; Strobel, Oliver; Werner, Jens; Büchler, Markus W.; Weichert, Wilko; Trumpp, Andreas und Sprick, Martin R.
(2016):
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.
In: Nature Medicine, Bd. 22, Nr. 3: S. 278-287